CHAPTER 130:  SYNTHETIC ALTERNATIVE DRUGS
Section
   130.01   Definitions
   130.02   Unlawful sale or delivery of synthetic substances
   130.03   Unlawful possession of synthetic substances
 
   130.99   Penalty
§ 130.01  DEFINITIONS.
   For the purpose of this chapter, the following definitions shall apply unless the context clearly indicates or requires a different meaning.
   SYNTHETIC CANNABINOID.  Any laboratory- created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog containing a cannabinoid receptor agonist, such as:
      (1)   JWH-007 (1-pentyl-2-methyl-3-(1- naphthoyl)indole);
      (2)   JWH-015 ((2-Methyl-1-propyl-1H- indol-3-yl)-1-naphthalenylmethanone);
      (3)   JWH-018 (1-pentyl-3-(1- naphthoyl)indole);
      (4)   JWH-019 (1-hexyl-3-(naphthalen-1- oyl)indole);
      (5)   JWH-073 (naphthalen-1-yl-(1- butylindol-3-yl)methanone);
      (6)   JWH-081 (4-methoxynaphthalen-1-yl- (1-pentylindol-3-yl)methanone);
      (7)   JWH-098 (4-methoxynaphthalen-1-yl- (1-pentyl-2-methylindol-3-yl)methanone);
      (8)   JWH-122 (1-pentyl-3-(4-methyl-1- naphthoyl)indole);
      (9)   JWH-164 (7-methoxynaphthalen-1-yl- (1-pentylindol-3-yl)methanone;
      (10)   JWH-200 (1-(2-morpholin-4- ylethyl)indol-3-yl)-naphthalen-1-ylmethanone);
      (11)   JWH-203 (2-(2-chlorophenyl)-1-(1- pentylindol-3-yl)ethanone;
      (12)   JWH-210 (4-ethylnaphthalen-1-yl-(1- pentylindol-3-yl)methanone;
      (13)   JWH-250 (1-pentyl-3-(2- methoxyphenylacetyl)indole);
      (14)   JWH-251 (1-pentyl-3-(2- methylphenylacetyl)indole);
      (15)   JWH-398 (1-pentyl-3-(4-chloro-1- naphthoyl)indole);
      (16)   HU-210 ((6aR,10aR)-9- (Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2- yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol);
      (17)   HU-211 ((6aS,10aS)-9- (Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2- yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol);
      (18)   HU-308 ([(lR,2R,5R)-2-[2,6- dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7- dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol);
      (19)   HU-331 ((3-hydroxy-2-[(1R,6R)-3- methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5- pentyl-2,5-cyclohexadiene-1,4-dione);
      (20)   CP 55,940 (2-[(1R,2R,5R)-5-hydroxy- 2-(3-hydroxypropyl) cyclohexyl]- 5-(2-methyloctan- 2-yl)phenol);
      (21)   CP 47,497 (2-[(1R,3S)-3- hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol) and its homologues;
      (22)   WIN 55,212-2 ((R)-(+)-[2,3-Dihydro- 5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de)-1,4-benzoxazin-6-yl]-1- nepthalenylmethanone);
      (23)   RCS-4 ((4-methoxyphenyl)(1-pentyl- 1H-indol-3-yl)methanone);
      (24)   RCS-8 (1-(1-(2-cyclohexylethyl)- 1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone).
   SYNTHETIC STIMULANT.  Any compound which is a federally controlled Schedule I substance such as cathinone, methcathinone, MDMA and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance which have a stimulant effect on the central nervous system. Upon banning, any of the following substances or substances which contain the described characteristics shall be considered a SYNTHETIC STIMULANT:
      (1)   3-Fluoromethcathinone;
      (2)   4-Fluoromethcathinone (other name: flephedrone);
      (3)   3,4-Methylenedioxymethcathinone (other name: methylone, MDMC);
      (4)   3,4-Methylenedioxypyrovalerone (other name: MDPV);
      (5)   4-Methylmethcathinon (other names: mephedrone, 4-MMC);
      (6)   4-Methoxymethcathinone (other names: methedrone, bk-PMMA, PMMC);
      (7)   4-Ethylmethcathinone (other name: 4- EMC);
      (8)   Ethcathinone;
      (9)   Beta-keto-N- methylbenzodioxyolylpropylamine (other names: butylone, bk-MBDB);
      (10)   Napthylpyrovalerone (other names: naphyrone, NRG-1);
      (11)   N,N-dimethylcathinone (other name: metamfepramone);
      (12)   Alpha-pyrrolidinopropiophenone (other name: alpha-PPP);
      (13)   4-methoxy-alpha- pyrrolidinopropiophenone (other name: MOPPP);
      (14)   3,4-methylenedioxy-alpha- pyrrolidinopropiophenone (other name: MDPPP);
      (15)   Alpha-pyrrolidinovalerophenone (other name: alpha-PVP);
      (16)   6,7-kihydro-5H-indeno(5,6-d)-1,3- dioxal-6-amine) (other name: MDAI);
      (17)   Any compound that is structurally derived from 2-amino-1-phenyl-1-propanone by modification or substitution in any of the following ways:
         (a)   In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
         (b)   At the 3-position with an alkyl substituent;
         (c)   At the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups;
         (d)   Or by inclusion of the nitrogen atom in a cyclic structure.
(Ord. O-2012.01, passed 3-13-2012)
§ 130.02  UNLAWFUL SALE OR DELIVERY OF SYNTHETIC SUBSTANCES.
   It shall be unlawful for any person to sell, offer for sale or deliver any product containing a synthetic cannabinoid or synthetic stimulant.
(Ord. O-2012.01, passed 3-13-2012) Penalty, see § 130.99
§ 130.03  UNLAWFUL POSSESSION OF SYNTHETIC SUBSTANCES.
   It shall be unlawful for any person to knowingly possess a product containing a synthetic cannabinoid or synthetic stimulant.
(Ord. O-2012.01, passed 3-13-2012) Penalty, see § 130.99
§ 130.99  PENALTY.
   (A)   Any person 17 years of age or older found to be in violation of § 130.02 shall be subject to a fine of not less than $500 and not more than $750 for each violation thereof. Any person under the age of 17 who violates § 130.02 shall pay court cost, and in addition to paying the fine, shall complete not less than 20 hours of community service. Any person 17 years of age or older who violates § 130.02 may, in addition to paying the above fine, be sentenced to not more than six months’ incarceration. Notwithstanding age, any individual found in violation of § 130.03 must complete drug counseling.
   (B)   Any person 17 years of age or older found to be in violation of § 130.03 shall be subject to a fine of not less than $100 and not more than $750 for each violation thereof. Any person 17 years of age or older who violates § 130.03 may, in addition to paying the above fine, be sentenced to not more than 30 days incarceration. Notwithstanding age, any individual found in violation of § 130.03 must complete drug counseling. Any person under the age of 17 who violates § 130.03, in addition to drug counseling shall only pay court cost.
   (C)   Each violation of this chapter, or everyday a violation continues to exist, shall constitute a new and separate violation.
(Ord. O-2012.01, passed 3-13-2012)